GDNF family receptor complexes are emerging drug targets
about
Gene therapy in Parkinson's disease: rationale and current statusResearch advances of arteminA GRFa2/Prop1/stem (GPS) cell niche in the pituitaryGDNF-based therapies, GDNF-producing interneurons, and trophic support of the dopaminergic nigrostriatal pathway. Implications for Parkinson's diseaseNeuroimmune crosstalk in the central nervous system and its significance for neurological diseasesCD2-associated protein (CD2AP) enhances casitas B lineage lymphoma-3/c (Cbl-3/c)-mediated Ret isoform-specific ubiquitination and degradation via its amino-terminal Src homology 3 domains.c-Jun in Schwann cells promotes axonal regeneration and motoneuron survival via paracrine signaling.Activation of mGlu3 receptors stimulates the production of GDNF in striatal neurons.A Novel Small Molecule GDNF Receptor RET Agonist, BT13, Promotes Neurite Growth from Sensory Neurons in Vitro and Attenuates Experimental Neuropathy in the Rat.Sciatic nerve injury in adult rats causes distinct changes in the central projections of sensory neurons expressing different glial cell line-derived neurotrophic factor family receptorsRole of BDNF and GDNF in drug reward and relapse: a reviewThe effect of lentivirus-mediated PSPN genetic engineering bone marrow mesenchymal stem cells on Parkinson's disease rat modelTargeting eNOS and beyond: emerging heterogeneity of the role of endothelial Rho proteins in stroke protectionCharacterization of axons expressing the artemin receptor in the female rat urinary bladder: a comparison with other major neuronal populationsHeparan sulfate proteoglycan syndecan-3 is a novel receptor for GDNF, neurturin, and arteminCharacterization of Drosophila GDNF receptor-like and evidence for its evolutionarily conserved interaction with neural cell adhesion molecule (NCAM)/FasII.Expression of receptors for glial cell line-derived neurotrophic factor family ligands in sacral spinal cord reveals separate targets of pelvic afferent fibers.Glial cell line-derived neurotrophic factor reverses alcohol-induced allostasis of the mesolimbic dopaminergic system: implications for alcohol reward and seekingImpact of methamphetamine on dopamine neurons in primates is dependent on age: implications for development of Parkinson's disease.Cis and trans RET signaling control the survival and central projection growth of rapidly adapting mechanoreceptors.Tricyclic Antidepressant Amitriptyline-induced Glial Cell Line-derived Neurotrophic Factor Production Involves Pertussis Toxin-sensitive Gαi/o Activation in Astroglial Cells.Gene expression in skin, muscle, and dorsal root ganglion after plantar incision in the rat.Lipid Rafts Are Physiologic Membrane Microdomains Necessary for the Morphogenic and Developmental Functions of Glial Cell Line-Derived Neurotrophic Factor In Vivo.NTS-Polyplex: a potential nanocarrier for neurotrophic therapy of Parkinson's diseaseRET signaling does not modulate MPTP toxicity but is required for regeneration of dopaminergic axon terminals.Artemin stimulates radio- and chemo-resistance by promoting TWIST1-BCL-2-dependent cancer stem cell-like behavior in mammary carcinoma cells.IB4(+) nociceptors mediate persistent muscle pain induced by GDNF.Neurotrophic factor receptor RET: structure, cell biology, and inherited diseases.Molecular pathways and genetic aspects of Parkinson's disease: from bench to bedside.CDNF protects the nigrostriatal dopamine system and promotes recovery after MPTP treatment in mice.Treatment of Parkinson's disease with trophic factors.Rac1 is a critical mediator of endothelium-derived neurotrophic activity.GDNF therapy for Parkinson's disease.Characterization of bladder sensory neurons in the context of myelination, receptors for pain modulators, and acute responses to bladder inflammation.Geraniol ameliorates the motor behavior and neurotrophic factors inadequacy in MPTP-induced mice model of Parkinson's disease.The fundamental unit of pain is the cell.Triggering neurotrophic factor actions through adenosine A2A receptor activation: implications for neuroprotectionFunctional mechanism of neuroprotection by inhibitors of type B monoamine oxidase in Parkinson's disease.Dynamic changes in dopamine neuron function after DNSP-11 treatment: effects in vivo and increased ERK 1/2 phosphorylation in vitro.Growth factors and neuropathic pain.
P2860
Q22241423-94564B90-E842-4C11-B68D-C170965F0EBAQ26992299-74315FC2-3F57-4FA2-AD5F-68377321F918Q27350395-ADAD250A-981B-4EFD-88D2-A461539712E4Q28088320-61C83A2E-D289-44CD-AE6B-C99DCC77364BQ28269903-EFE2DC1C-EF26-4EF2-B8FF-94AFA4D9F33CQ30009496-C32F11CF-F273-4E68-A593-6EBA62DA97AAQ30519558-22E42158-37AB-4F3C-840F-78672CE3C478Q33492743-7E446F0E-E582-417A-954A-BBF986119F07Q33819340-38A30016-6F35-4ECB-8930-3F47F195E2F2Q33906411-25CE58C9-EA0D-4154-BB72-727D67F4C730Q33939940-EF88A6E6-621F-4847-BD58-A14835366CBAQ34041921-547F65DB-0870-407A-A693-7EB3F7EA1A08Q34088803-10238E66-2831-4D9F-AFE9-190BA0149736Q34207320-B55787BF-3A6F-4976-88FE-21941FBF252AQ34483129-5B3AFC9C-4DE9-45EF-A0CA-FC4D9410502FQ34532713-C1B5C3A7-F950-440A-8CE6-F238B7C8B167Q34629284-2807BE99-B427-4170-A7A0-057B3D0F8214Q35131215-5D142EE8-ED1D-44E1-B5F2-35FEBBDA3655Q35147689-204103C7-E0E0-42D2-8260-75AE0CC26A8BQ35534002-6DFD2AF5-E607-4119-BD29-E2EA0B96AB6BQ35662230-BDA861BF-1F39-492D-8229-AF0FDFCE2166Q36075486-5BAEA6A9-9013-4391-9130-49CE21848C0DQ36084422-F599C042-C9C2-418F-8180-60A6591557A4Q36089698-0B5D4B3B-08EF-4108-BEC9-D9462F548E6FQ36289043-CB2D8915-D1FA-4DF5-95EE-2DEBBC61AD1CQ36466583-36D88AF1-9ECB-40F1-9ED9-2C960812A734Q36533296-1AB5BD62-2F00-4B65-8771-74A7DDA9773DQ36970334-731E4DA9-A1C9-4E4A-AC56-43E7A6DD4857Q37021321-D2F4FB99-EDCB-474D-B899-D478C815A244Q37121244-6AD8DF80-CD25-41F2-914B-9E1FC7A750DFQ37131259-97806A18-9F95-4F43-ABE1-E8D77F8ACA00Q37157708-5A1AC15D-BFF2-4B00-9F99-9F1AA55A73F9Q37203371-45207169-30BB-4A8A-ACC8-9A4B9C9BA6B0Q37285369-19AB3AA2-394F-4F99-89F1-4A2807C7FA60Q37298364-D0E071F5-942B-4678-B072-5047689D9AF2Q37381403-E9332ACF-7350-457E-969C-0C517C8AD221Q37512421-FB04E682-CD85-4639-8587-35CC81E1333CQ37578490-DB265650-5023-483A-BDFC-6788AC0601B5Q37706984-439682C4-9754-49AB-A8CB-5DE086D3EABFQ37843774-8E4612C6-13B6-43DB-8BA9-00C09E980496
P2860
GDNF family receptor complexes are emerging drug targets
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
GDNF family receptor complexes are emerging drug targets
@ast
GDNF family receptor complexes are emerging drug targets
@en
GDNF family receptor complexes are emerging drug targets
@nl
type
label
GDNF family receptor complexes are emerging drug targets
@ast
GDNF family receptor complexes are emerging drug targets
@en
GDNF family receptor complexes are emerging drug targets
@nl
prefLabel
GDNF family receptor complexes are emerging drug targets
@ast
GDNF family receptor complexes are emerging drug targets
@en
GDNF family receptor complexes are emerging drug targets
@nl
P3181
P1476
GDNF family receptor complexes are emerging drug targets
@en
P2093
Mart Saarma
P3181
P356
10.1016/J.TIPS.2006.12.005
P407
P577
2007-01-10T00:00:00Z